Table 1 Maturation status of DCs derived... | American Society of Hematology

Table 1

Maturation status of DCs derived from patients with malignant melanoma

Patient no.	Sex	Age, y	Stage*	Distant metastasis*	DC generation†	DEC-205, %‡	MFI DEC-205§	CD83, %‡	MFI CD83§
1	Female	73	IV	M1a	Adherence	97	210	96	91
2	Male	52	IV	M1c	Elutriation	98	244	97	50
3	Female	65	IIIc	—	Adherence	96	238	93	59
4	Male	66	IV	M1b	Adherence	93	193	98	143
5	Female	46	IV	—	Elutriation	92	92	88	63

Patient no.	Sex	Age, y	Stage*	Distant metastasis*	DC generation†	DEC-205, %‡	MFI DEC-205§	CD83, %‡	MFI CD83§
1	Female	73	IV	M1a	Adherence	97	210	96	91
2	Male	52	IV	M1c	Elutriation	98	244	97	50
3	Female	65	IIIc	—	Adherence	96	238	93	59
4	Male	66	IV	M1b	Adherence	93	193	98	143
5	Female	46	IV	—	Elutriation	92	92	88	63

DC indicates dendritic cell; MFI, mean fluorescence intensity; and —, no distant metastasis.

According to Balch et al.³⁵

DC generation from monocytes enriched by the Elutra counterflow elutriation system or the standard gradient centrifugation/adherence technique.

Percentage of DEC-205-positive or CD83-positive DCs.

MFI above background.